[Bjonnh.net]# _

Authors: Kathryn M. Nelson ORCID , Jonathan Bisson ORCID , Gurpreet Singh ORCID , James G. Graham ORCID , Shao-Nong Chen ORCID , J. Brent Friesen ORCID , Jayme L. Dahlin ORCID , Matthias Niemitz ORCID , Michael A. Walters ORCID , Guido F. Pauli ORCID
Journal: Journal of Medicinal Chemistry (RoMEO status: White)
Subjects:
This Perspective of the published essential medicinal chemistry of cannabidiol (CBD) provides evidence that the popularization of CBD-fortified or CBD-labeled health products and CBD-associated health claims lacks a rigorous scientific foundation. CBD’s reputation as a cure-all puts it in the same class as other “natural” panaceas, where valid ethnobotanicals are reduced to single, purportedly active ingredients. Such reductionist approaches oversimplify useful, chemically complex mixtures in an attempt to rationalize the commercial utility of natural compounds and exploit the “natural” label.
Read More...
categories publications science
Authors: Kathryn M. Nelson ORCID , Jayme L. Dahlin ORCID , Jonathan Bisson ORCID , James Graham , Guido F. Pauli ORCID , Michael A. Walters ORCID
Journal: Journal of Medicinal Chemistry (RoMEO status: White)
Subjects:
Curcumin is a constituent (up to ∼5%) of the traditional medicine known as turmeric. Interest in the therapeutic use of turmeric and the relative ease of isolation of curcuminoids has led to their extensive investigation. Curcumin has recently been classified as both a PAINS (pan-assay interference compounds) and an IMPS (invalid metabolic panaceas) candidate. The likely false activity of curcumin in vitro and in vivo has resulted in >120 clinical trials of curcuminoids against several diseases.
Read More...
categories publications science